Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 134441-61-5 | MDL No. : | MFCD04973120 |
Formula : | C11H21NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PZTAGFCBNDBBFZ-SECBINFHSA-N |
M.W : | 215.29 | Pubchem ID : | 6933953 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.91 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 62.56 |
TPSA : | 49.77 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.66 cm/s |
Log Po/w (iLOGP) : | 2.74 |
Log Po/w (XLOGP3) : | 1.34 |
Log Po/w (WLOGP) : | 1.39 |
Log Po/w (MLOGP) : | 1.15 |
Log Po/w (SILICOS-IT) : | 0.93 |
Consensus Log Po/w : | 1.51 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.75 |
Solubility : | 3.78 mg/ml ; 0.0176 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.99 |
Solubility : | 2.22 mg/ml ; 0.0103 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.11 |
Solubility : | 16.7 mg/ml ; 0.0774 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.74 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With trifluoroacetic acid In dichloromethane at 20℃; for 1 h; | Trifluoroacetic acid (3 ml) was carefully added to a stirring solution of tert-butyl (2R)-2- (hydroxymethyl) PIPERIDINE-L-CARBOXYLATE (1.15 g, obtained as described in TETRAHEDRON, 5 8 (2002), 1343-1354) in DCM (3 ml) and stirred at room temperature for 1 hour. Volatiles were removed IN VACUO and the oil thus obtained dissolved in methanol (60 ml), and neutralized by addition of MP-Carbonate resin (polymer supported carbonate reagent ex. Argonaut Technologies Inc.) (approximately I g) whilst stirring at room temperature for 2 hours. The resin was filtered, washed with methanol (3 x 30 ml) and the filtrate concentrated. The resulting oil was dissolved in DCM (30 ml) and dried (MgSO4) before filtration and solvent removal to afford a grey oil (615 mg, 100percent); NMR spectrum (DMSO-D6) 1.44-1. 51 (m, 2H), 1.61 (m, 1H), 1.70-1. 78 (m, 3H), 2.84 (m, 1H), 3.03 (m, 1H), 3.21 (d, 1H), 3.49 (m, 1H), 3.57 (dd, 1H), 5.01 (bs, 1H), 7.65 (bs, 1H) ; Mass spectrum M+ 116. |
100% | With trifluoroacetic acid In dichloromethane at 20℃; for 1 h; | Trifluoroacetic acid (3 ml) was carefully added to a stirred solution of tert-butyl (2R)-2- (hydroxymethyl)piperidine-l-carboxylate (1.15 g, obtained as described in Tetrahedron, 58 (2002), 1343 - 1354) in DCM (3 ml). The reaction mixture was then stirred at room temperature for 1 hour. Volatiles were removed in vacuo and the oil thus obtained dissolved in methanol (60 ml), and neutralized by addition of MP-Carbonate resin (polymer supported carbonate reagent ex. Argonaut Technologies Inc.) (approximately Ig) whilst stirring at room temperature for 2 hours. The resin was filtered, washed with methanol (3 x 30 ml) and the filtrate concentrated. The resulting oil was dissolved in DCM (30 ml) and dried (MgSO4) before filtration and solvent removal to afford a grey oil (615 mg, 100percent); NMR spectrum 1.44 - 1.51 (m, 2H), 1.61 (m, IH), 1.70 - 1.78 (m, 3H), 2.84 (m, IH), 3.03 (m, IH), 3.21 (d, IH), 3.49 (m, IH), 3.57 (dd, IH), 5.01 (bs, IH), 7.65 (bs, IH); Mass spectrum M+ 116. |
100% | With trifluoroacetic acid In dichloromethane at 20℃; for 1 h; | The (2R)-piperidin-2-ylmethanol used as starting material was prepared as follows: Trifluoroacetic acid (3 ml) was carefully added to a stirring solution of tert-butyl (2R)-2- (hydroxymethyl)piperidine-l-carboxylate (1.15 g, obtained as described in Tetrahedron, 58 (2002), 1343 - 1354) in DCM (3 ml) and stirred at room temperature for 1 hour. Volatiles were removed in vacuo and the oil thus obtained dissolved in methanol (60 ml), and neutralized by addition of MP-Carbonate resin (polymer supported carbonate reagent ex. Argonaut Technologies Inc.) (approximately 1 g) whilst stirring at room temperature for 2 hours. The resin was filtered, washed with methanol (3 x 30 ml) and the filtrate concentrated. The resulting oil was dissolved in DCM (30 ml) and dried (MgSO4) before filtration and solvent removal to afford a grey oil (615 mg, 100percent); NMR spectrum 1.44 - 1.51 (m, 2H), 1.61 (m, IH), 1.70 - 1.78 (m, 3H), 2.84 (m, IH), 3.03 (m, IH), 3.21 (d, IH), 3.49 (m, IH), 3.57 (dd, IH), 5.01 (bs, IH), 7.65 (bs, IH): Mass spectrum M+ 116. |
[ 443955-98-4 ]
(3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.92
[ 250249-85-5 ]
(R)-1-Boc-piperidine-2-ethanol
Similarity: 0.92
[ 2044704-67-6 ]
tert-Butyl 4-(1-amino-2-hydroxyethyl)piperidine-1-carboxylate hydrochloride
Similarity: 0.91
[ 85275-45-2 ]
tert-Butyl 3-hydroxypiperidine-1-carboxylate
Similarity: 0.90
[ 443955-98-4 ]
(3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.92
[ 710972-40-0 ]
tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate
Similarity: 0.92
[ 250249-85-5 ]
(R)-1-Boc-piperidine-2-ethanol
Similarity: 0.92
[ 2044704-67-6 ]
tert-Butyl 4-(1-amino-2-hydroxyethyl)piperidine-1-carboxylate hydrochloride
Similarity: 0.91
[ 443955-98-4 ]
(3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.92
[ 710972-40-0 ]
tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate
Similarity: 0.92
[ 250249-85-5 ]
(R)-1-Boc-piperidine-2-ethanol
Similarity: 0.92
[ 2044704-67-6 ]
tert-Butyl 4-(1-amino-2-hydroxyethyl)piperidine-1-carboxylate hydrochloride
Similarity: 0.91
[ 443955-98-4 ]
(3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.92
[ 710972-40-0 ]
tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate
Similarity: 0.92
[ 250249-85-5 ]
(R)-1-Boc-piperidine-2-ethanol
Similarity: 0.92
[ 2044704-67-6 ]
tert-Butyl 4-(1-amino-2-hydroxyethyl)piperidine-1-carboxylate hydrochloride
Similarity: 0.91
[ 85275-45-2 ]
tert-Butyl 3-hydroxypiperidine-1-carboxylate
Similarity: 0.90